Atopic dermatitis, commonly known as eczema, is a chronic inflammatory skin condition characterized by red, itchy, and inflamed patches of skin. It is often associated with other allergic conditions like asthma and hay fever. Atopic dermatitis is more prevalent in children but can persist into adulthood. The exact cause is not fully understood, but a combination of genetic, environmental, and immune system factors is believed to contribute to its development. The symptoms of atopic dermatitis include dry and sensitive skin, intense itching, red or brownish patches, and in severe cases, blisters or oozing lesions. The condition can be triggered or exacerbated by factors such as certain foods, allergens, stress, or irritants like harsh soaps. While atopic dermatitis is a chronic condition without a cure, proper management and avoidance of triggers can significantly improve symptoms and enhance the quality of life for those affected.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
Atopic dermatitis, also known as eczema, is a chronic skin condition affecting millions worldwide. According to the Mayo Clinic, this condition is characterized by dry, itchy and inflamed skin. The condition is chronic and can flare-up at times. In this article, we will explore the common causes, symptoms and potential treatments for atopic dermatitis.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...